Heat shock factor 1 (HSF1) is highly expressed in various malignancies and is a potential modulator of tumor progression. Emerging evidence suggests that HSF1 activation in stromal cells is closely related to poor patient prognosis. However, the role of HSF1 in oral squamous cell carcinoma (OSCC) remains elusive. We aimed to investigate the function of HSF1 in cancer-associated fibroblasts (CAFs) of the tumor microenvironment (TME) and in tumor development. In the present study, we found that HSF1 was Taken together, these data suggest that HSF1 expression in CAFs drive OSCC progression, and could serve as an independent prognostic marker of patients with OSCC.
Heat shock factor 1 (HSF1) is highly expressed in various malignancies and is a potential modulator of tumor progression. Emerging evidence suggests that HSF1 activation in stromal cells is closely related to poor patient prognosis. However, the role of HSF1 in oral squamous cell carcinoma (OSCC) remains elusive. We aimed to investigate the function of HSF1 in cancer-associated fibroblasts (CAFs) of the tumor microenvironment (TME) and in tumor development. In the present study, we found that HSF1 was Taken together, these data suggest that HSF1 expression in CAFs drive OSCC progression, and could serve as an independent prognostic marker of patients with OSCC.
Thus, HSF1 is a potent mediator of OSCC malignancy.
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| INTRODUC TI ON
Oral squamous cell carcinoma, the sixth most common cancer worldwide, is typically detected in advanced stages. 1, 2 Despite advanced treatment strategies, the 5-year OS rate has remained at approximately 50%. 3 Local invasion and distant metastasis are the predominant causes of death in patients; 4 however, the underlying mechanism has not been fully explored.
Tumor microenvironment is known to have a prominent role in tumor progression. 5 As a major component of TME, CAFs participate in tumor initiation and evolution, and they promote tumor cell proliferation, angiogenesis, invasion and chemotherapy resistance by various mechanisms. [6] [7] [8] Unlike NFs, which usually form a tumor-suppressive microenvironment, CAFs are involved in ECM remodeling, tumorenhancing inflammation, and secretion of various growth factors and cytokines that regulate EMT. [9] [10] [11] Recently, activated CAFs have been thought to be characterized by the expression of α-SMA, FSP-1, FAP, fibronectin and Vimentin. [12] [13] [14] Of note, increased infiltration of CAFs in tumor stroma is correlated with poor prognosis in many malignancies, including breast cancer, colorectal cancer and oral cancer. [15] [16] [17] Studies investigating the activation of HSF1 in CAFs have been particularly enlightening. As the dominant regulator of the heat shock response, HSF1 is an 82-kD transcription factor that is located in the cytoplasm and responds to stress conditions. 18, 19 Moreover, HSF1 is involved in the phosphorylation, nuclear accumulation and trimerization of proteins, and it can bind to HSE to induce the transcription of target genes [20] [21] [22] and participate in many biological processes, including growth, development, survival, and inflammation. [23] [24] [25] However, the activation of HSF1 has been widely correlated with tumor initiation, growth, invasion and metastasis, and HSF1 has been shown to function as a tumor promoter and potential diagnostic biomarker. [26] [27] [28] [29] Recently, there has been growing concern regarding the role of HSF1 in the modulation of the TME. In particular, HSF1 remodels the TME by reprogramming stromal fibroblasts to promote tumor invasion and metastasis. Most α-SMApositive CAFs have strong nuclear HSF1 staining in different tumor types including skin, lung, esophageal, gastric, colon and prostate carcinoma. 26 Despite accumulating evidence on the effects of CAFs on TME modulation during tumor progression, little is known about HSF1 expression in CAFs that is responsible for TME reprogramming resulting in the promotion of OSCC invasion and metastasis. In the present study, we investigated the role of HSF1 in CAFs and tumor cells and then analyzed its relationship with the clinicopathological parameters and prognosis of OSCC patients. Furthermore, we characterized the functional role of HSF1 in CAFs during crosstalk with tumor cells and cancer progression and metastasis. Our results may facilitate the identification of novel therapeutic implications of HSF1 expression in CAFs in OSCC. 
| MATERIAL S AND ME THODS

| Patients
| Immunohistochemistry
Paraffin sections (4 μm) of tissues were dewaxed in xylene, rehydrated in gradient ethanol, and incubated with 3% hydrogen peroxide for 10 minutes. After antigen retrieval and blocking were carried out, the sections were incubated overnight with antibodies 
| Evaluation of immunoreactivity
| Real-time RT-PCR and western blotting
Real-time RT-PCR and western blotting were carried out as previously described in our study. 32 Primer sequences for real-time RT-PCR are listed in Table S1 . Primary antibodies for western blotting were as follows: β-actin as a control (1:500; Proteintech, Rosemont, IL, USA), HSF1 (1:1000; Abcam), α-SMA (1:400; Abcam), FSP-1 (1:1000;
Abcam), FAP (1:800; Abcam), E-cadherin (1:1000; Abcam), Vimentin
(1:500; Santa Cruz Biotechnology) and Snail (1:500; Abcam).
| Cell proliferation assay
Cells were plated in 96-well plates (3000 cells/well) for 24 hours incubation. CCK-8 (10 μL; Dojindo Molecular Technologies, Kumamoto, Japan) was added to each well and incubated for 4 hours.
Absorbance was determined at 0, 2, 4, and 6 days at 450 nm.
| Wound-healing and invasion assays
Cells were plated in six-well plates and grown to 90% confluence. 
| Three-dimensional coculture system
Fibroblasts were resuspended in FBS, and then type IA collagen, 5 × DMEM and reconstitution buffer (50 mmol/L NaOH, 260 mmol/L NaHCO 3 , and 200 mmol/L HEPES) were sequentially added to the fibroblasts and uniformly mixed. The mixture was added to 12-well plates and allowed to solidify in an incubator at 37°C for 30-60 minutes. Cal27 cells were resuspended in the coculture medium and then transferred onto the surface of the gelatinized fibroblast layer. The coculture medium was refreshed every day. After 3 days, the gels were transferred onto a supporter in six-well plates and were cultured at the air-liquid interface. Then, the gels were fixed with 4% PFA, embedded in paraffin and cut into 4-μm sections for H&E staining.
| Cell transfection
Human HSF1-encoding lentiviral vectors were constructed by GeneChem Co., Ltd (Shanghai, China). The sequence for HSF1-targeting shRNA is CCAAGTACTTCAAGCACAA, and the scrambled sequence is TTCTCCGAACGTGTCACGT. CAFs were seeded in six-well plates and cultured to 40% confluence, and lentiviruses were used to infect CAFs according to the manufacturer's instructions. Cells in the control group (CAFs-G) and in the experimental group (CAFs-H) were cultured at 37°C in a 5% CO 2 incubator for 8-12 hours, and then the medium was refreshed. Fluorescence microscopy was used to observe transfection efficiency, and real-time RT-PCR and western blotting were used to detect shRNA interference efficiency 72 hours later.
| Tumor xenografts
BALB/c nude mice (4-6 weeks old, female) were purchased from Vital River Laboratory Animal Technology Co. Ltd (Beijing, China) and raised under specific pathogen-free conditions in the Animal Core Facility of Nanjing Medical University. All experimental procedures were F I G U R E 2 Survival analysis of 121 patients with oral squamous cell carcinoma (OSCC). A, Survival curves of 121 OSCC patients with low or high expression of α-smooth muscle actin (α-SMA) (log-rank test, P < 0.001). B, Survival curves of 121 OSCC patients with low or high expression of heat shock factor 1 (HSF1) in the tumor stroma (log-rank test, P < 0.001). C, Survival curves of 121 OSCC patients with low or high expression of HSF1 in tumor cells (log-rank test, P = 0.001). L, low expression; H, high expression CAFs-G or CAFs-H in the right axilla of mice. Tumor sizes were measured and tumor volumes were calculated using the equation: volume (mm 3 ) = (length × width 2 )/2. At approximately 24 days, the mice were killed, and xenograft tumors were dissected for subsequent analyses.
| Statistical analysis
Student's t test, chi-squared test and Fisher's exact test were carried out to evaluate the relationship of α-SMA, HSF1 in stroma, and HSF1 in tumor cells with clinicopathological parameters. Pearson's correlation analysis was used to estimate the correlation among HSF1 in tumor cells, α-SMA and HSF1 in stroma. Cox regression models were used to assess the prognosis of patients. OS was evaluated by Kaplan-Meier analysis and the log-rank test. Statistical significance in in vitro and in vivo experiments was assessed using one-way ANOVA and independentsamples t test. P < 0.05 was considered statistically significant.
| RE SULTS
| Infiltration of CAFs is associated with OSCC progression
In the present study, we stained OSCC specimens with PBS instead of antibodies against α-SMA and HSF1 as negative controls and observed no staining for α-SMA or HSF-1 ( Figure S1 ). Then, we stained for α-SMA, a specific marker for CAFs, and evalu- However, there was no significant relationship between α-SMA expression and gender, age, tumor location or distant metastasis (Table 1) . Nevertheless, the expression of α-SMA in stroma was associated with poor OS (Figure 2A , P < 0.001) and exerted a poor prognostic impact on the survival rate according to univariate Cox analyses (P = 0.003, Table 2 ). Based on these results, we concluded that the stromal infiltration of CAFs is significantly as- (Table 1) . However, high expression of HSF1 in the stroma was significantly correlated with OS ( Figure 2B , P < 0.001). Univariate and multivariate Cox regression analyses indicated that HSF1 in the stroma was an independent prognostic factor (P < 0.001, P = 0.001, Tables 2 and 3 , respectively). Thus, HSF1 expression in CAFs is closely related to poor prognosis and severely affects the survival rate of OSCC patients. (Table 1) . Moreover, the high expression of HSF1 in tumor cells exerted a poor prognostic impact on the survival rate ( Figure 2C , P = 0.003, Table 2 ). Remarkably, the expression of HSF1 in tumor Table S2 ).
TA B L E 3 Multivariate Cox regression analysis of overall survival
| Heat shock factor 1 expression in CAFs promotes OSCC progression
| Heat shock factor 1 expression in tumor cells promotes OSCC progression
| Heat shock factor 1 is upregulated in primary CAFs
In vitro, CAFs and NFs were established to further explore the role of 
| Heat shock factor 1-positive CAFs enhance proliferation, migration and invasion in cancer cells
To verify the function of HSF1-positive CAFs on cancer cells, we treated Cal27 cells with CM from CAFs (Cal27-C) or NFs (Cal27-N).
Cal27-C cells presented fibroblast-like phenotypes, showing a more elongated and spindle-like shape compared with Cal27-N cells ( Figure 7A ). Western blotting showed an increased expression of mesenchymal markers Vimentin and Snail in Cal27-C cells, whereas no significant change was observed in the epithelial marker E-cadherin ( Figure 7B ). Meanwhile, Cal27-C cells showed higher proliferation than Cal27-N cells ( Figure 7C ). Wound-healing assay showed that Cal27-C cells filled the scratched area after 24 hours, whereas larger gaps were observed with control cells, which indicated a significantly higher migratory ability of Cal27-C cells than Cal27-N cells ( Figure 7D ). Transwell assays also showed a 3.38-fold increase in Cal27-C cell invasiveness over that observed in control cells ( Figure 7E , P < 0.01). Furthermore, the 3-D coculture system indicated that HSF1-positive CAFs could induce cancer cells to invade collagen; additionally, these cancer cells were more invasive than cancer cells cocultured with NFs ( Figure 7F, 3 .33-fold, P < 0.05).
These data indicate that HSF1 expression in CAFs could induce EMT and enhance proliferation, migration and invasion in OSCC.
To further characterize HSF1 expression in CAFs, cell transfection was carried out to knock down HSF1 in CAFs. Indeed, HSF1 expression was decreased in CAFs-H ( Figure 8A , B, P < 0.01). Meanwhile, mRNA expression of three CAFs markers was decreased in response to HSF1 silencing ( Figure 8C ). Western blotting also showed that the protein level of α-SMA, FSP-1 and FAP was downregulated in
CAFs-H ( Figure 8D ). Then, we treated Cal27 cells with CM from
CAFs-G or CAFs-H. On the contrary, knockdown of HSF1 in CAFs caused fibroblast-like Cal27 cells to become "cobblestone-shaped" 
| D ISCUSS I ON
Evidence has shown that the close communication between TME and cancer cells contributes to invasion and metastasis in tumors. 33, 34 As However, the mechanism has not been fully elucidated in OSCC.
Cancer-associated fibroblasts support invasion and metastasis of cancer cells by remodeling the stroma. 38, 39 HSF1 activation has been reported as a crucial regulator in the transcriptional reprogramming of the stroma to form a tumor-supportive environment. 26 Accumulating evidence suggests that HSF1 is overexpressed in various malignant tumors and functions as a potential diagnostic biomarker. 18, 19, [27] [28] [29] 40, 41 Our data show that HSF1 expression in tumor cells was significantly correlated with pathological grade, recurrence and death, and high HSF1 expression in cancer cells had a significantly poor prognostic impact on survival outcomes. Our findings on 121 OSCC samples are consistent with the results of the prior studies, showing that HSF1 expression was higher in OSCC tissues than in normal tissues and that high nuclear HSF1 expression was significantly related to tumor size and histopathological grade. Importantly, we had more tissue samples than Ishiwata et al. 41 Interestingly, we also found that the high expression of HSF1 in stromal CAFs had a close relationship with recurrence and mortality in OSCC patients, and multivariate regression analysis indicated that HSF1 in CAFs was an independent prognostic factor. The results were in accordance with the previous studies in breast, lung, and esophageal cancer, showing that HSF1 activation in the stroma is associated with poor patient outcomes. 26, 40 Furthermore, the expression of HSF1 in CAFs was significantly and independently correlated with that in tumor cells, which was consistent with the studies of Scherz-Shouval et al. 26 Taken together, our results suggest that HSF1 has an important role in regulating the interaction between the stroma and cancer cells, which go "hand in hand" to facilitate tumor progression.
Based on our knowledge, we conclude that HSF1 in CAFs is an independent prognostic factor of OSCC, and high HSF1 expression in both CAFs and cancer cells can improve our ability to predict OSCC patient outcomes. Thus, assessing HSF1 expression in both stroma and tumor cells might help to diagnose and guide treatment choices in OSCC progression.
Results of clinical specimens show that HSF1 in stroma could function as an independent prognostic factor, which reminds us of the vital role of HSF1 in CAFs on tumor progression. Indeed, the results of xenograft models confirm the role of HSF1 in CAFs in promoting tumor growth. In addition, in vitro studies have shown that HSF1 has multiple carcinogenic effects, such as regulating cell proliferation, migration and invasion, and inducing EMT. These results were supported by a recent study which showed that HSF1 is important for tumor progression and that it enhances cell migration and plays a critical role in EMT. 42, 43 These data may provide an explanation for F I G U R E 9 Heat shock factor 1 (HSF1) knockdown in cancer-associated fibroblasts (CAFs) decreases tumor growth in vivo. A, General observation of tumor-bearing nude mice s.c. coinjected with Cal27 cells and CAFs-GV248-shRNA-HSF1 (CAFs-H) or CAFs-GV248-NC (CAFs-G) (n = 6). B, Tumor tissues were resected after 24 d. C, Volumes of xenograft tumors in each group. D, Body weight measurements in each group. Data represent the mean ± SD in C and D; *P < 0.05, **P < 0.01 ns, no significance. E, Representative immunohistochemical staining for α-smooth muscle actin (α-SMA), E-cadherin and Vimentin in xenograft tumor tissues from the Cal27 + CAFs-H and Cal27 + CAFs-G groups (400×) the high expression of HSF1 in CAFs in promoting OSCC progression.
However, we have not further studied how HSF1 in CAFs can build a "bridge" between CAFs and cancer cells to promote tumor development in OSCC. It is suggested that CAFs can secrete growth factors, cytokines and chemokines to form a microenvironment conducive to tumor metastasis. 10, 11, 44 According to studies by Scherz-Shouval et al, transforming growth factor beta (TGF-β) and SDF1, two cytokines secreted by CAFs, play a critical role in stromal HSF1 promoting tumor growth of adjacent cells. 13, 16, 26, 45 However, further study is warranted to confirm the potential mechanism underlying the regulation of CAFs by HSF1 during crosstalk with tumor cells and tumor progression.
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